Cost analysis of treating cardiovascular diseases in a super-specialty hospital

Atul Kumar1, Vijaydeep Siddharth1, Soubam Iboyaima Singh1

  • 1Department of Hospital Administration, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Plos One
|January 5, 2022
PubMed

Insights

Economic evaluation of cardiovascular disease (CVD) treatment in India reveals significant inpatient and equipment costs. Rheumatic heart disease treatment is most expensive, though overall costs are lower than in developed nations.

Area of Science:

  • Health Economics
  • Cardiology
  • Public Health Policy

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health burden.
  • Economic evaluations are crucial for optimizing resource allocation in healthcare, particularly in developing countries with limited data.
  • Understanding the cost of CVD treatment is essential for healthcare policy and planning.

Purpose of the Study:

  • To analyze resource consumption and calculate the cost of treating cardiovascular disease patients in a tertiary care hospital in India.
  • To compare the cost of treating different types of CVDs.
  • To provide data for healthcare policy reforms in India.

Main Methods:

  • An observational, descriptive study conducted at the All India Institute of Medical Sciences, New Delhi, from April 2017 to June 2018.
  • Inclusion of common CVDs such as Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, and Cardiac Arrhythmias.
  • Utilized Traditional Costing and Time-Driven Activity-Based Costing (TDABC) methods for cost computation, analyzing medical records of 100 admitted patients.

Main Results:

  • Per bed per day costs ranged from Indian Rupee (INR) 18,774 (US$ 289) in pediatric cardiology wards to INR 28,144 (US$ 434) in the Cardiac Care Unit.
  • Inpatient costs formed approximately 70% of the total cost, with equipment (over 50%) and human resources (28%) being major components.
  • The average cost per patient for treating any CVD was INR 2,47,822 (US$ 3842), with Rheumatic Heart Disease being the most expensive to treat.

Conclusions:

  • Cardiovascular disease treatment costs in India are substantial, with significant contributions from inpatient stays and medical equipment.
  • Rheumatic Heart Disease treatment incurs the highest costs among studied CVDs.
  • The findings suggest that CVD treatment costs in India are lower compared to developed countries, providing valuable insights for Indian healthcare policy makers.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
59
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
46
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
85
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
50
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.7K